Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis

Paul Sun Woo Kim, Jacqueline Tu, Kelvin Truong, Gloria Fong, William Luu, Peter Barclay, Melanie Wong, Li‐Chuen Wong

Open source

DOI
10.1111/ajd.70118
Published
2026-04-07
Container
Australasian Journal of Dermatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ajd.70118,
  title = {Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis},
  author = {Paul Sun Woo Kim and Jacqueline Tu and Kelvin Truong and Gloria Fong and William Luu and Peter Barclay and Melanie Wong and Li‐Chuen Wong},
  year = {2026},
  journal = {Australasian Journal of Dermatology},
  doi = {10.1111/ajd.70118},
  url = {https://doi.org/10.1111/ajd.70118}
}

RIS

TY  - JOUR
TI  - Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis
AU  - Paul Sun Woo Kim
AU  - Jacqueline Tu
AU  - Kelvin Truong
AU  - Gloria Fong
AU  - William Luu
AU  - Peter Barclay
AU  - Melanie Wong
AU  - Li‐Chuen Wong
PY  - 2026
JO  - Australasian Journal of Dermatology
DO  - 10.1111/ajd.70118
UR  - https://doi.org/10.1111/ajd.70118
ER  - 

APA

Kim, P. S. W., Tu, J., Truong, K., Fong, G., Luu, W., Barclay, P., Wong, M., & Wong, L. (2026). Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.70118

Source records